ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 204 filers reported holding ROIVANT SCIENCES LTD in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,023,040 | +155.9% | 87,589 | +61.7% | 0.00% | +50.0% |
Q1 2023 | $399,804 | -29.8% | 54,174 | -24.0% | 0.00% | 0.0% |
Q4 2022 | $569,575 | +621.0% | 71,286 | +189.3% | 0.00% | – |
Q3 2022 | $79,000 | -27.5% | 24,640 | -7.8% | 0.00% | -100.0% |
Q2 2022 | $109,000 | -81.0% | 26,716 | -77.0% | 0.00% | -50.0% |
Q1 2022 | $573,000 | – | 115,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VI Management, LLC | 1,119,489 | $13,075,632 | 99.02% |
Patient Square Capital LP | 12,639,920 | $147,634,266 | 81.13% |
QVT Financial LP | 112,541,536 | $1,314,485,140 | 74.33% |
Two Seas Capital LP | 7,915,232 | $92,449,910 | 18.59% |
Octagon Capital Advisors LP | 4,367,000 | $51,006,560 | 7.84% |
SB INVESTMENT ADVISERS (UK) LTD | 73,031,667 | $853,009,871 | 7.02% |
Decheng Capital Management III (Cayman), LLC | 1,459,700 | $17,049,296 | 5.69% |
Anchorage Capital Group, L.L.C. | 4,832,642 | $56,445,259 | 5.10% |
Rubric Capital Management LP | 10,500,000 | $122,640,000 | 4.60% |
Artia Global Partners LP | 914,023 | $10,675,789 | 4.44% |